• head_banner_01

China wholesale Chloride 104 - Semaglutide for Type 2 Diabetes – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

To be a result of ours specialty and repair consciousness, our corporation has won a good popularity amid consumers everywhere in the environment for Sodium Mercaptoacetate, 660-27-5, Diisopropylamine Dichloroacetate, Our business has been devoting that "customer first" and committed to helping shoppers expand their small business, so that they become the Big Boss !
China wholesale Chloride 104 - Semaglutide for Type 2 Diabetes – Gentolex Detail:

Product Detail

Name  Semaglutide
CAS number  910463-68-2
Molecular formula  C187H291N45O59
Molecular weight  4113.57754
EINECS Number  203-405-2

Synonyms

Sermaglutide; Semaglutide fandachem; Semaglutide impurity; Sermaglutide USP/EP; semaglutide; Sermaglutide CAS 910463 68 2; Ozempic, 

Description

Semaglutide is a new generation of GLP-1 (glucagon-like peptide-1) analogs, and semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which has a better effect in the treatment of type 2 diabetes. Novo Nordisk has completed 6 Phase IIIa studies of semaglutide injection, and submitted a new drug registration application for semaglutide weekly injection to the U.S. Food and Drug Administration (FDA) on December 5, 2016. A Marketing Authorization Application (MAA) was also submitted to the European Medicines Agency (EMA).

Compared with liraglutide, semaglutide has a longer aliphatic chain and increased hydrophobicity, but semaglutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced. After PEG modification, it can not only bind closely to albumin, cover the enzymatic hydrolysis site of DPP-4, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.

Application

Semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which is more effective in treating type 2 diabetes.

Bioactivity

Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC0113-0217) is a long-acting glucagon-like peptide 1 (GLP-1) analog, an agonist of GLP-1receptor, with a potential type 2 Therapeutic efficacy of diabetes mellitus (T2DM).

Quality System

In general, quality system and assurance is in place covering all stage of production of the finished product. Adequate manufacturing and control operations are performed in compliance with the approved procedures/ specifications. Change control and Deviation handling system is in place, and necessary impact assessment and investigation were conducted. Proper procedures are in place to ensure quality of product prior to release into the market.


Product detail pictures:

China wholesale Chloride 104 - Semaglutide for Type 2 Diabetes – Gentolex detail pictures

China wholesale Chloride 104 - Semaglutide for Type 2 Diabetes – Gentolex detail pictures


Related Product Guide:

It adheres on the tenet "Honest, industrious, enterprising, innovative" to acquire new solutions continuously. It regards prospects, success as its personal success. Let us build prosperous future hand in hand for China wholesale Chloride 104 - Semaglutide for Type 2 Diabetes – Gentolex , The product will supply to all over the world, such as: Lisbon, Swansea, Netherlands, Our team knows well the market demands in different countries, and is capable of supplying suitable quality products and solutions at the best prices to different markets. Our company has already set up a experienced, creative and responsible team to develop clients with the multi-win principle.
  • This is a very professional wholesaler, we always come to their company for procurement, good quality and cheap.
    5 Stars By Sabina from Czech republic - 2018.12.14 15:26
    The customer service staff is very patient and has a positive and progressive attitude to our interest, so that we can have a comprehensive understanding of the product and finally we reached an agreement, thanks!
    5 Stars By Federico Michael Di Marco from Kenya - 2018.05.13 17:00
    Write your message here and send it to us